- Q3 net loss was $17.8M ($0.36 per share), compared to $14.7M ($1.09 per share) in prior year period.
- Cash, equivalents and marketable securities stood at $163.3M as of Sept 30, 2026, funding operations into 2029.
- IND submissions for OKI-345 and OKI-355 planned for 1H 2027.
Why is $OKUR moving today? · SEC 8-K archive
$OKUR SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $OKUR: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $OKUR filing catalyst
Why did $OKUR trigger an AI stock catalyst alert?
$OKUR triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +0.5/10). Headline: OnKure Therapeutics Reports Q3 Net Loss of $17.8M, Cash Runway Into 2029. Key points: - Q3 net loss was $17.8M ($0.36 per share), compared to $14.7M ($1.09 per share) in prior year period. - Cash, equivalents and marketable securities stood at $163.3M as of Sept 30, 2026, funding operations into 2029. - IND submissions for OKI-345 and OKI-355 planned for 1H 2027.
How did $OKUR stock react after the SEC filing?
After the SEC 8-K for $OKUR, observed market reaction: T0 price $2.59. Past moves do not guarantee future results.
Where can I get real-time $OKUR SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $OKUR via Telegram and the VIP Web Terminal from €10/month.